By integrating gene-silencing techniques targeting B7H6 with the potential regulatory effects on TRPC6 and TRPM7, we aim to explore a novel approach to overcoming drug resistance in gastric cancer therapy. The gene discussed is NCR3LG1; the disease is gastric cancer.